# A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers

> **NCT06916897** · PHASE1 · COMPLETED · sponsor: **Edgewise Therapeutics, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** sevasemten
- **DRUG:** Verapamil

## Key facts

- **NCT ID:** NCT06916897
- **Lead sponsor:** Edgewise Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-08
- **Primary completion:** 2025-02-22
- **Final completion:** 2025-02-22
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916897, "A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06916897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*